title: Alternative intensive induction chemotherapeutic regimens in MYC expressing diffuse large B-cell lymphoma.
authors.affiliation: Division of Hematology and Oncology.
authors.forename: Judy P
authors.initials: JP
authors.lastname: Tsai
authors.forename: Wade T
authors.initials: WT
authors.lastname: Iams
authors.forename: John P
authors.initials: JP
authors.lastname: Greer
authors.forename: David S
authors.initials: DS
authors.lastname: Morgan
authors.forename: Shaoying
authors.initials: S
authors.lastname: Li
authors.forename: Nishitha M
authors.initials: NM
authors.lastname: Reddy
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D056915:DNA Copy Number Variations; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D060828:Induction Chemotherapy / Q000379:methods*; D059785:Karyotype; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: C000595707:BCL2 protein, human; C489427:MYC protein, human; D019253:Proto-Oncogene Proteins c-bcl-2; D016271:Proto-Oncogene Proteins c-myc